Synergistic effect of donor-specific blood transfusion and a short course of deoxyspergualin in rat kidney transplantation

Transplant International

Volumn 9, Issue 4, 1996, Pages 353-358

  Tanabe, Kazunari ^a   Yasuo, Mineko ^a   Nemoto, Kyuichi ^b   Takahashi, Kota ^a   Toma, Hiroshi ^a   Ota, Kazuo ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NIPPON KAYAKU CO LTD   (Japan)

Author keywords

Deoxyspergualin, kidney, rat; Donor specific transfusion, rat, kidney; Kidney, rat, donor specific transfusion; Rat, kidney, deoxyspergualin

Indexed keywords

15 DEOXYSPERGUALIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; LYMPHOCYTE; MALE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RAT; SUPPRESSOR CELL; SURVIVAL;

ANIMALS; BLOOD TRANSFUSION; CYTOTOXICITY TESTS, IMMUNOLOGIC; DRUG SYNERGISM; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT SURVIVAL; GUANIDINES; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; LYMPHOCYTE CULTURE TEST, MIXED; RADIATION TOLERANCE; RATS; RATS, INBRED BN; RATS, INBRED LEW; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029987276     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00335694     Document Type: Article

References (23)

1. Amemiya H, Suzuki S, Manabe H, Fukao K, Iwasaki Y, Dohi K, Isono K, Orita K, Yamanaka N (1988) 15-Deoxyspergualin as an immunosuppressive agent in dogs. Transplant Proc 20: 229-232
2. Amemiya H, Suzuki S, Ota K, Takahashi K, Sonoda T, Ishibashi M, Omoto R, Koyama I, Dohi K, Fukuda Y, Fukao K (1990) A novel rescue drug, 15-deoxyspergualin. First clinical trials for recurrent graft rejection in renal recipients. Transplantation 49: 337-343
3. Cosimi AB, Colvin RB, Burton RC, Rubin RH, Goldstein G, Kung PC, Hansen N, Delmonico F (1981) Use of monoclonal antibodies to T-cell subsets for immunologie monitoring and treatment in recipients of renal allografts. N Engl J Med 305:308
4. Dickneite G, Schorlemmer HU, Weinmann E, Bartlett RR, Sedlacek HH (1987) Skin transplantation in rats and monkeys: evaluation of efficient treatment with 15-deoxyspergualin. Transplant Proc 19: 4244-4247
5. Fujii H, Takada T, Nemoto K, Abe F, Fujii A, Takeuchi T (1989) In vitro immunosuppressive properties of spergualins to murine T cell response. J Antibiot (Tokyo) 42: 788-794
6. Fujii H, Takada T, Nemoto K, Yamashita T, Abe F, Fujii A, Takeuchi T (1990) Deoxyspergualin directly suppresses antibody formation in vivo and in vitro. J Antibiot (Tokyo) 43: 213-219
7. Hess AD (1985) Effect of interleukin 2 on the immunosuppressive action of cyclosporine. Transplantation 39: 62-68
8. Lee S (1967) An improved technique of renal transplantation in the rat. Surgery 61: 771-773
9. Leventhal JR, Flores HC, Gruber SA, Figueroa J, Platt JL, Carlos Manivel J, Bach FH, Matas AJ, Morton Bolman R III (1992) Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model. Transplantation 54: 26-31
10. Majoor GD, Gaar MJWH van de, Breda Vriesman PJC van, Gunther E (1985) Genetic control of production of IgG antibody against allogeneic erythrocytes in rats. Transplantation 39: 216-217
11. Marchman W, Araneda D, DeMasi R, Taylor D, Larkin E, Alqaisi M, Thomas F (1992) Prolongation of xenograft survival after combination therapy with 15-deoxyspergualin and total-lymphoid irradiation in the hamster-to-rat cardiac xenograft model. Transplantation 53: 30-34
12. Morikawa K, Oseko F, Morikawa S (1992) The suppressive effect of deoxyspergualin on the differentiation of human B cell lymphocytes maturing into immunoglobulin-producing cells. Transplantation 54: 526-531
13. Nakajima Y, Yabuuchi H, Kanehiro H, Wada T, Hisanaga M, Nakano H (1989) Prolongation of pancreatic islet xenograft survival and thymus alteration by 15-deoxyspergualin. Transplantation 48: 351-352
14. Nemoto K, Abe F, Nakamura T, Ishizuka M, Takeuchi T, Umezawa H (1987) Blastogenic response and the release of interleukin 1 and 2 by spleen cells obtained from rat skin allograft recipients administered with 15-deoxyspergualin. J Antibiot (Tokyo) 40:1062-1064
15. Nemoto K, Hayashi M, Sugawara Y, Ito J, Abe F, Takita T, Nakamura T, Takeuchi T (1988) Biological activities of deoxyspergualin in autoimmune disease mice. J Antibiot (Tokyo) 41: 1253-1259
16. Okazaki H, Sato T, Jimbo M, Senga S, Amada N, Oguma S (1991) Prophylactic use of deoxyspergualin in living related renal transplantation. Transplant Proc 23: 1094-1095
17. 31P nuclear magnetic resonance spectrography and its effect on rat heart transplantation. Transplantation 46: 669-672
18. Takeuchi T, Iinuma H, Kunimoto S, Masuda T, Ishizuka M, Takeuchi M, Hamada M, Naganawa H, Kondo S, Umezawa H (1981) A new antitumor antibiotic, spergualin: isolation and antitumor activity. J Antibiot (Tokyo) 34: 1619-1621
19. Tanabe K, Takahashi K, Nemoto K, Okada M, Yasuo M, Hayasaka Y, Toma H, Ota K (1995) Effect of deoxyspergualin on vascular rejection in canine kidney transplantation. J Urol 152: 562-566
20. Thomson AW (1990) FK506 enters the clinic. Immunol Today 11: 35-36
21. Valdivia LS, Monden M, Gotoh M, Nakano Y, Tono T, Mori T (1990) Evidence that deoxyspergualin prevents sensitization and first-set cardiac xenograft rejection in rats by suppression of antibody formation. Transplantation 50: 132-134
22. Valdivia LA, Monden M, Gotoh M, Tono T, Nakano Y, Mori T (1991) Suppressor cells induced by donor-specific transfusion and deoxyspergualin in rat cardiac xenografts. Transplantation 52: 594-599
23. Walter P, Thies J, Harbauer G, Dickneite G, Sedlacek HH, Vonnahme F (1986) Allogeneic heart transplantation in the rat with a new antitumoral drug -15-deoxyspergualin. Transplant Proc 18: 1293-1294